FDA Inspection 1200624 - Roswell Park Cancer Institute Corporation. Div. of Pathology - March 13, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Roswell Park Cancer Institute Corporation. Div. of Pathology, with an inspection on March 13, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Roswell Park Cancer Institute Corporation. Div. of Pathology
Inspection Date: March 13, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · acfe24f0-a550-470c-8072-99afe4b47ef8